Combined analysis of N′-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in the urine of cigarette smokers and e-cigarette users
Individual Clinical
Pharmacokinetics
& Abuse Liability
Pharmacokinetics
Kotandeniya (2015)
Supraventricular tachycardia and acute confusion following ingestion of e-cigarette fluid containing AB-FUBINACA and ADB-FUBINACA: a case report with quantitative analysis of serum drug concentrations
Individual Clinical
Safety
Adverse Effects
Lam (2017)
Short‐term respiratory effects of e‐cigarettes in healthy individuals and smokers with asthma
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of User
Lappas (2018)
Changes in puffing behavior among smokers who switched from tobacco to electronic cigarettes
Individual Clinical
User Topography
Lee (2015)
Examining Daily Electronic Cigarette Puff Topography Among Established and Nonestablished Cigarette Smokers in their Natural Environment
Individual Clinical
User Topography
Lee (2018)
Emissions from Electronic Cigarettes: Assessing Vapers' Intake of Toxic Compounds, Secondhand Exposures, and the Associated Health Impacts
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
Logue (2017)
Incidence of electronic cigarette exposures in children skyrockets in Arizona
Individual Clinical
Safety
Adverse Effects
Lovecchio and Zoph (2015)
Abuse liability assessment of an electronic cigarette in combustible cigarette smokers.
Individual Clinical
Pharmacokinetics
& Abuse Liability
Abuse Liability
Maloney (2019)
How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious self-experiments in the nineteenth century
Individual Clinical
Safety
Adverse Effects
Mayer (2014)
Measuring PM2.5, Ultrafine Particles, Nicotine Air and Wipe Samples Following the Use of Electronic Cigarettes
Individual Clinical
Chemical
Analysis
Melstrom (2017)